Nephros, Inc.
Nephros, Inc. scores highest on Torque (71) and lowest on Anchor (44). Its PosiPenta is 56.23 out of 100, around the middle of similar companies.
On the Penta Grid this week, Nephros, Inc. is Grid #195 of 837 in the Healthcare sector in United States, and Grid #1,085 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Nephros, Inc. | 56.23 | 47 | 63 | 56 | 71 | 44 |
| Elutia Inc. | 40.08 | 26 | 34 | 59 | 38 | 44 |
| Dogwood Therapeutics, Inc. | 52.52 | 91 | 44 | 15 | 66 | 47 |
| Harvard Bioscience, Inc. | 43.40 | 14 | 58 | 88 | 18 | 40 |
| SCYNEXIS, Inc. | 41.29 | 45 | 28 | 30 | 65 | 38 |
| Instil Bio, Inc. | 31.50 | 47 | 10 | 23 | 42 | 35 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 24.33 |
| P/B ratio | 3.31 |
EEarnings
| Trailing EPS | ₹14.21 |
| Forward EPS | ₹19.89 |
NNitro
| Price | 345.71 |
| 52-week high | 608.07 |
| 52-week low | 251.94 |
| Fall from 52-week high | 43.1% |
TTorque
| Return on equity (ROE) | 16.10% |
| Debt-to-equity | 0.07 |
AAnchor
| Beta (price swings) | 1.64 |
| Market cap | ₹375 Cr |
| Insider holding | 19.45% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Nephros, Inc.'s PosiPenta score?
Nephros, Inc.'s PosiPenta is 56.23 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Nephros, Inc. stand on the Penta Grid?
On the Penta Grid this week, Nephros, Inc. is Grid #195 of 837 in the Healthcare sector in United States, and Grid #1,085 of 4,000 in United States.
Which PosiPenta pillar is strongest for Nephros, Inc.?
Torque (durability), with a score of 71 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Nephros, Inc.?
Anchor (stability and dividends), with a score of 44 out of 100: around the middle of similar companies.
Has Nephros, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.85 points, from 53.38 to 56.23.
PositoAI is for research and education only and is not investment advice.